SALT LAKE CITY (AP) _ Myriad Genetics Inc. (MYGN) on Tuesday reported fiscal fourth-quarter net income of $12.9 million.
The Salt Lake City-based company said it had profit of 19 cents per share. Earnings, adjusted for one-time gains and costs, came to 30 cents per share.
The results topped Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for earnings of 26 cents per share.
The molecular diagnostic company posted revenue of $200.5 million in the period, also beating Street forecasts. Five analysts surveyed by Zacks expected $193.5 million.
Myriad shares have climbed 53 percent since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $25.55, a decrease of 15 percent in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MYGN at https://www.zacks.com/ap/MYGN
_____
Keywords: Myriad Genetics, Earnings Report